HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 2 of 2
ANBL1232 Response & Biology Risk Factors in Patients with Non-High-Risk Neuroblastoma
In this study we are using new biologic features, in addition to the standard risk factors, to help decide which subjects need treatment and what the best treatment is.
Related PI: Rochelle Bagatell, MD
Related Conditions: Neuroblastoma, Pediatric Neurology, Oncology
NEPENTHE - Next Generation Personalized Neuroblastoma Therapy
This is a clinical trial for patients with neuroblastoma that has returned (relapsed) or has not responded to standard treatment.
Related PI: Yael P. Mossé, MD
Related Conditions: Neuroblastoma, Oncology